Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
78.2M
-
Shares change
-
+78.1M
-
Total reported value, excl. options
-
$3.74B
-
Value change
-
+$3.73B
-
Number of buys
-
108
-
Price
-
$48.30
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2019
109 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q2 2019.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.2M shares
of 152M outstanding shares and own 51.51% of the company stock.
Largest 10 shareholders include Viking Global Investors LP (38.4M shares), Matrix Capital Management Company, LP (17.3M shares), Senator Investment Group LP (5.11M shares), BAKER BROS. ADVISORS LP (1.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (900K shares), MILLENNIUM MANAGEMENT LLC (707K shares), BlackRock Inc. (661K shares), BAMCO INC /NY/ (657K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (625K shares), and FMR LLC (606K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.